Related Experiment Video
Updated: May 23, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Cardio-oncology, from Guidelines to Practice: Filling the Gap - an Eastern European Viewpoint
Andreea Cristina Ivănescu1,2, Patricia Lorena Dulf3,4, Daniel Vasile Dulf3,5
1Department 4, Carol Davila University of Medicine and Pharmacy Bucharest, Romania.
Abstract:
Significant gaps persist in the real-world implementation of cardio-oncology guidelines, particularly in resource-limited settings. This viewpoint explores the application of evidence-based cardiovascular prevention, surveillance and management strategies amongst Romanian physicians treating cancer patients, enabling comparison with international data. A national, anonymous, online survey (September to November 2024) targeted cardiologists, oncologists, haematologists and internists. The 21-item questionnaire assessed institutional context, clinical practices, and adherence to international recommendations. A total of 190 responses were analysed. Centres with dedicated cardio-oncology teams and university affiliation more frequently apply structured risk stratification, monitor subclinical toxicity, and prescribe prophylactic pharmacotherapy. Centres without such teams demonstrate less consistent implementation of cardioprotective strategies and long-term follow-up. Cardiologists were more likely than oncologists to modify cancer therapy or initiate cardioprotective treatment in cases of early dysfunction. Long-term follow-up was inconsistently implemented and dependent on the institutional cardio-oncology organisation. Cardio-oncology practice in Romania remains heterogeneous, influenced by specialty, institutional resources and experience, highlighting the need for structured national programmes and interdisciplinary training.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Standards of Care II
Coronary Artery Disease V: Interprofessional Care
Standards of Care I
